Concord Medical Services
5 hedge funds and large institutions have $666K invested in Concord Medical Services in 2020 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% more ownership
Funds ownership: 0.04% → 0.04% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
33% less capital invested
Capital invested by funds: $991K → $666K (-$325K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$4.03K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.66K |
CCM Hedge Fund Activity: Q1 2020 in Review
5 of the 4,546 institutional investors tracked by Wall St. Rank reported a position in Concord Medical Services (CCM) for Q1 2020, worth a combined $666K — down 33% from $991K a quarter earlier.
Fund positioning in CCM was balanced in Q1 2020: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $4.03K. The largest seller was UBS Group, cutting an estimated $1.66K.
- 5 institutional investors held Concord Medical Services (CCM) as of Q1 2020, unchanged from Q4 2019.
- Funds reported $666K of Concord Medical Services stock for Q1 2020, down 33% quarter-over-quarter.
- 0 funds opened new Concord Medical Services positions in Q1 2020 and 0 closed out.
- The largest Concord Medical Services buyer in Q1 2020 was Renaissance Technologies, an estimated $4.03K added.
- The largest Concord Medical Services seller in Q1 2020 was UBS Group, an estimated $1.66K sold.
Based on aggregated 13F filings for Q1 2020.